219 related articles for article (PubMed ID: 684426)
1. Rebound insomnia: a new clinical syndrome.
Kales A; Scharf MB; Kales JD
Science; 1978 Sep; 201(4360):1039-41. PubMed ID: 684426
[TBL] [Abstract][Full Text] [Related]
2. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
Kales A; Scharf MB; Kales JD; Soldatos CR
JAMA; 1979 Apr; 241(16):1692-5. PubMed ID: 430730
[TBL] [Abstract][Full Text] [Related]
3. [Does a rebound insomnia following benzodiazepine administration exist?].
Ladewig D
Dtsch Med Wochenschr; 1980 Oct; 105(43):1483-4. PubMed ID: 7428651
[No Abstract] [Full Text] [Related]
4. Rebound insomnia and elimination half-life: assessment of individual subject response.
Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
[TBL] [Abstract][Full Text] [Related]
5. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
6. Hypnotics: rebound insomnia and residual sequelae.
Nicholson AN
Br J Clin Pharmacol; 1980 Mar; 9(3):223-5. PubMed ID: 7362730
[No Abstract] [Full Text] [Related]
7. Rebound insomnia and rebound anxiety: a review.
Kales A; Soldatos CR; Bixler EO; Kales JD
Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
[TBL] [Abstract][Full Text] [Related]
8. Rebound insomnia and hypnotic self administration.
Roehrs T; Merlotti L; Zorick F; Roth T
Psychopharmacology (Berl); 1992; 107(4):480-4. PubMed ID: 1603890
[TBL] [Abstract][Full Text] [Related]
9. Rebound insomnia: a critical review.
Gillin JC; Spinweber CL; Johnson LC
J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine hypnotics and insomnia.
Kales A
Hosp Pract (Off Ed); 1990 Sep; 25 Suppl 3():7-21; discussion 22-3. PubMed ID: 1976124
[TBL] [Abstract][Full Text] [Related]
11. The use of short- and long-acting hypnotics in clinical medicine.
Nicholson AN
Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):61S-69S. PubMed ID: 6133538
[TBL] [Abstract][Full Text] [Related]
12. Long-term sleep laboratory evaluation of flunitrazepam.
Scharf MB; Bixler EO; Kales A; Soldatos CR
Pharmacology; 1979; 19(4):173-81. PubMed ID: 42931
[TBL] [Abstract][Full Text] [Related]
13. Rebound insomnia and newer hypnotics.
Lader M
Psychopharmacology (Berl); 1992; 108(3):248-55. PubMed ID: 1523276
[TBL] [Abstract][Full Text] [Related]
14. Early morning insomnia with rapidly eliminated benzodiazepines.
Kales A; Soldatos CR; Bixler EO; Kales JD
Science; 1983 Apr; 220(4592):95-7. PubMed ID: 6131538
[TBL] [Abstract][Full Text] [Related]
15. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
Kales A; Bixler EO; Vela-Bueno A; Soldatos CR; Niklaus DE; Manfredi RL
Clin Pharmacol Ther; 1986 Oct; 40(4):378-86. PubMed ID: 3530586
[TBL] [Abstract][Full Text] [Related]
16. Main neuroendocrine features and therapy in primary sleep troubles.
Amihăesei IC; Mungiu OC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
[TBL] [Abstract][Full Text] [Related]
17. Aspects of short-term use of two benzodiazepine hypnotics in the elderly.
Murphy P; Hindmarch I; Hyland CM
Age Ageing; 1982 Nov; 11(4):222-8. PubMed ID: 6129788
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
Scharf MB
J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment of insomnia: indications and complications.
Syvälahti EK
Ann Clin Res; 1985; 17(5):265-72. PubMed ID: 3909922
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine withdrawal syndrome seizures.
Martínez-Cano H; Vela-Bueno A; de Iceta M; Pomalima R; Martínez-Gras I
Pharmacopsychiatry; 1995 Nov; 28(6):257-62. PubMed ID: 8773293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]